US Stock MarketDetailed Quotes
NMRD Nemaura Medical
- 0.053
- -0.006-10.77%
15min DelayClose May 1 16:00 ET
1.54MMarket Cap-137P/E (TTM)
0.056High0.051Low10.84KVolume0.051Open0.060Pre Close566.75Turnover0.06%Turnover RatioLossP/E (Static)28.90MShares1.25052wk High-0.09P/B904.04KFloat Cap0.05152wk Low--Dividend TTM16.91MShs Float68.000Historical High--Div YieldTTM8.18%Amplitude0.051Historical Low0.052Avg Price1Lot Size
About Nemaura Medical Company
Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.
Company Profile
SymbolNMRD
Company NameNemaura Medical
Listing DateJan 25, 2018
Founded2013
CEODr. Dewan Fazlul Hoque Chowdhury
MarketPink Market
Employees38
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address57 West 57th Street,Manhattan
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10019
Phone1-646-416-8000
Company Executives
- Name
- Position
- Salary
- Dr. Dewan Fazlul Hoque Chowdhury
- Chairman of the Board, President, Chief Executive Officer, Acting Principal Financial Officer and Principal Accounting Officer
- 338.58K
- Dr. Arash Ghadar
- Chief Operating Officer
- --
- Bashir Timol
- Director and Chief Business Officer
- --
- Timothy Johnson
- Independent Director
- 6.18K
- Thomas Moore
- Independent Director
- 6.18K
- Dr. Salim Natha
- Independent Director
- 6.18K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg